User profiles for A C Reboli
Annette ReboliProfessor of medicine, Cooper medical school of Rowan University Verified email at rowan.edu Cited by 17548 |
Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials
…, JW Baddley, G Playford, AC Reboli… - Clinical infectious …, 2012 - academic.oup.com
(See the Editorial Commentary by Clancy and Nguyen, on pages 1123–5 .) Background.
Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence …
Invasive candidiasis (IC) is an important healthcare-related infection, with increasing incidence …
Executive summary: clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
…, L Ostrosky-Zeichner, AC Reboli… - Clinical Infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Erysipelothrix rhusiopathiae: an occupational pathogen
AC Reboli, WE Farrar - Clinical microbiology reviews, 1989 - Am Soc Microbiol
Erysipelothrix rhusiopathiae is a nonsporulating, gram-positive, rod-shaped bacterium which
was identified more than 100 years ago as the etiologic agent of swine erysipelas. Since …
was identified more than 100 years ago as the etiologic agent of swine erysipelas. Since …
Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
…, L Ostrosky-Zeichner, AC Reboli… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
[HTML][HTML] Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
…, L Ostrosky-Zeichner, AC Reboli… - … diseases: an official …, 2009 - ncbi.nlm.nih.gov
Guidelines for the management of patients with invasive candidiasis and mucosal candidiasis
were prepared by an Expert Panel of the Infectious Diseases Society of America. These …
were prepared by an Expert Panel of the Infectious Diseases Society of America. These …
[HTML][HTML] Anidulafungin versus fluconazole for invasive candidiasis
Background Anidulafungin, a new echinocandin, has potent activity against candida species.
We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority …
We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority …
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
…, L Ostrosky-Zeichner, AC Reboli… - Clinical infectious …, 2007 - academic.oup.com
Background. Invasive candidiasis is an important cause of morbidity and mortality among
patients with health care–associated infection. The echinocandins have potent fungicidal …
patients with health care–associated infection. The echinocandins have potent fungicidal …
[HTML][HTML] Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal …
This analysis describes the epidemiology and outcomes of invasive candidiasis caused by
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …
non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy …
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with …
…, DJ Winston, EJ Bow, G Garber, AC Reboli… - Annals of internal …, 2001 - acpjournals.org
Background: Amphotericin B deoxycholate is currently the standard empirical antifungal
therapy in neutropenic patients with cancer who have persistent fever that does not respond to …
therapy in neutropenic patients with cancer who have persistent fever that does not respond to …
Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization …
TJ Walsh, HC Standiford, AC Reboli… - Antimicrobial agents …, 1993 - Am Soc Microbiol
Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen in hospitals. Current
antimicrobial regimens for eradicating colonizing strains are not well defined and are often …
antimicrobial regimens for eradicating colonizing strains are not well defined and are often …